v3 Template
N

NRG Therapeutics, Ltd.

Biotechnology / Neuroscience ~520 employees
Founded
--
Employees (Est.)
~520
26 leaders known
Total Funding
$72.5M
Funding Rounds
3
Last Funding
2025-09-08

About NRG Therapeutics, Ltd.

NRG Therapeutics is a neuroscience-focused drug discovery company dedicated to developing new medicines for neurodegenerative disorders. The company aims to bring hope to patients by building a pipeline of disease-modifying drug candidates that restore mitochondrial function and slow or halt the progression of diseases like Parkinson's and Amyotrophic Lateral Sclerosis (ALS), also known as Motor Neurone Disease (MND).

Products & Services

mPTP Inhibitors:A pipeline of potential first-in-class, brain-penetrant, oral small molecule inhibitors of the mitochondrial permeability transition pore (mPTP), aimed at restoring mitochondrial function and slowing or halting the progression of Parkinson's and ALS/MND.
NRG5051:First development candidate selected by NRG Therapeutics for the treatment of neurodegenerative diseases through mPTP inhibition.

Specialties

Mitochondrial Biology Neurodegenerative Disorders Drug Discovery for Parkinson's and ALS/MND mPTP Inhibitors

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series B
T: -
FT: Series B
A: 67000000
MR: -
FA: £50m ($67m)
FAN: 67000000
D: 2025-09-08
FD: 2025-09-08
8 investors
2 RT: Grant
T: -
FT: Grant
A: 5000000
MR: -
FA: 5M
FAN: 5000000
D: 2024-10-31
FD: 2024-10-31
1 investors
3 RT: Grant
T: -
FT: Grant
A: 500000
MR: -
FA: $500,000
FAN: 500000
D: 2023-02-22
FD: 2023-02-22
1 investors
Series B Latest
2025-09-08
$67.0M
8 investors (Pro only)
Grant 2024-10-31
$5.0M
Grant 2023-02-22
$500K

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

N

Neil Miller

CEO

J

Jonathan Savidge

Independent Non Executive Chair

R

Richard Rutter Ph.D.

CSO

G

Grant Hawthorne

COO

R

Rupert Sandbrink M.D. Ph.D

CMO

S

Seth Masters

VP Discovery Biology

View 23 more team members with Pro

Unlock Full Team Directory

Recent News

NRG Therapeutics, Ltd. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Neuroscience
Company Size
~520 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro